Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by MrMugsyon Aug 27, 2021 9:25am
138 Views
Post# 33775120

Cluey ... I'm not your advisor ...

Cluey ... I'm not your advisor ...There is nothing I want to advise you on Cluey.
If you don't get it, you just don't get it.
Don't worry about it - it's just the way your brain works.

Being part of cutting-edge technology or being involved in a complex ROW creation isn't for those who look for a steady 5-7% annual growth starting in the first year of operation as a public company.

It's like walking into a house with the plumbing roughed-in ... and ... going to where the kitchen sink will eventually be ... then looking for a water tap that doesn't exist yet and expecting to have clean running water.

Move on to Disney shares where you can continue your fairytale adventure (without actually owning any shares).  Leave this site for those who want to discuss GUD, present and future.

: )
<< Previous
Bullboard Posts
Next >>